Anna Nilson

Anna Nilson is currently the Head of Clinical Operations at Desentum Oy, a start-up company developing biological immunotherapeutic products for allergy. Prior to this, Anna was the Global Clinical Affairs Leader at PerkinElmer, where Anna led clinical studies on IVD products. Anna also worked as a Scientific Advisor at Bristol-Myers Squibb and Pfizer, focusing on medical affairs activities for various products. Anna has extensive experience in clinical research, with previous roles as Clinical Research Director at Novagenesis and Oy Medfiles Ltd, and Project Director at Hormos Medical Ltd. Anna holds a Master of Science (MSc) degree in Biology from the University of Turku.